Project Number 1R21NS113025-01 Agency/Funding Organization NINDS Funding Year 2019 View Full Project Details for A new approach to immunotherapy for ALS Research Categorization Primary Disease / Condition Multiple Dementias Lewy Body Dementias CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies Researcher and Organization Principal Investigator XU, ZUOSHANG Principal Investigator First Name ZUOSHANG Principal Investigator Last Name XU Awardee Organization UNIV OF MASSACHUSETTS MED SCH WORCESTER Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-358: NINDS Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) FY Overall Cost $460,625 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GUBITZ, AMELIE
